ResoundingHealth
Search
  
Basic Drug Info
Drug Name:Hydromorphone Hydrochloride
Manufacturer:Mallinckrodt Inc.
Other Info:

Hydromorphone hydrochloride tablets pose little risk of direct exposure to health care personnel and should be handled and disposed of prudently in accordance with hospital or institutional policy.

Significant absorption from dermal exposure is unlikely.

Patients and their families should be instructed to flush any hydromorphone hydrochloride tablets that are no longer needed.Access to abuseable drugs such as hydromorphone hydrochloride tablets presents an occupational hazard for addiction in the health care industry.

Routine procedures for handling controlled substances developed to protect the public may not be adequate to protect health care workers.

Implementation of more effective accounting procedures and measures to restrict access to drugs of this class (appropriate to the practice setting) may minimize the risk of self-administration by health care providers.



Clinical Trials:


Indications and Usage
Hydromorphone Hydrochloride Tablets are indicated for the management of pain in patients where an opioid analgesic is appropriate.
Pain -- An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Contraindications

Hydromorphone hydrochloride tablets are contraindicated in: patients with known hypersensitivity to hydromorphone, patients with respiratory depression in the absence of resuscitative equipment, and in patients with status asthmaticus.

Hydromorphone hydrochloride tablets are also contraindicated for use in obstetrical analgesia.
Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

LUNG FUNCTION DECREASED --

Status Asthmaticus -- A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts.

Warnings

Respiratory Depression– Respiratory depression is the chief hazard of hydromorphone hydrochloride tablets.

Respiratory depression is more likely to occur in the elderly, in the debilitated, and in those suffering from conditions accompanied by hypoxia or hypercapnia when even moderate therapeutic doses may dangerously decrease pulmonary ventilation.Hydromorphone hydrochloride tablets should be used with extreme caution in patients with chronic obstructive pulmonary disease or cor pulmonale, patients having a substantially decreased respiratory reserve, hypoxia, hypercapnia, or in patients with preexisting respiratory depression.

In such patients even usual therapeutic doses of opioid analgesics may decrease respiratory drive while simultaneously increasing airway resistance to the point of apnea.Hydromorphone hydrochloride tablets contain hydromorphone, which is a potent Schedule II controlled opioid agonist.

Schedule II opioid agonists, including morphine, oxymorphone, oxycodone, fentanyl, and methadone, have the highest potential for abuse and risk of producing respiratory depression.

Alcohol, other opioids and central nervous system depressants (sedative-hypnotics) potentiate the respiratory depressant effects of hydromorphone, increasing the risk of respiratory depression that might result in death.
Branded Drugs
The following US Branded drugs contain Hydromorphone Hydrochloride


PALLADONE -- PURDUE PHARMA LP

DILAUDID -- PURDUE PHARMACEUTICAL PRODUCTS LP

DILAUDID-HP -- PURDUE PHARMACEUTICAL PRODUCTS LP


This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.